Gilead Sciences Inc (GILD)

79.58 -0.42 (-0.52%) USD  |  NASDAQ  |  Mar 27, 16:00
80.10 +0.52 (+0.65%) After-Hours: 07:50
More

Gilead Sciences News

News

Headline
Wire
Time (ET)
Top Stocks for April 2023
Yahoo
03/27 16:49
Gilead Sciences Could Retreat Further From Here
Yahoo
03/27 09:25
Biotech Stock Roundup: ALT Obesity Data, GILD Exercises Option, INCY Drug Approval
Yahoo
03/23 13:51
Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know
Yahoo
03/22 17:50
Gilead (GILD) Announces OS Data on Yescarta From ZUMA-7 Study
Yahoo
03/22 14:38
Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities
Yahoo
03/22 12:00
Groups Around the World Work to Eliminate Hepatitis C by Meeting People Where They Are
Yahoo
03/22 09:30
Gilead's Flagship CAR T-cell Therapy Shows Improved Overall Survival In Pretreated Lymphoma Patients
Yahoo
03/21 13:19
Gilead Sciences Unit Kite Says Yescarta Showed 'Statistically Significant' Improvement in Overall Survival of Lymphoma Patients
MT Newswires
03/21 12:07
Nurix's (NRIX) Stock Up Due to License Option Exercise by Gilead
Yahoo
03/21 10:05
Kite’s Yescarta® CAR T-cell Therapy Demonstrates a Statistically Significant Improvement in Overall Survival for Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma
Yahoo
03/21 09:37
Gilead Exercises First License Option Under Agreement With Nurix Therapeutics
Yahoo
03/20 12:17
Gilead Sciences to License Nurix Therapeutics' Targeted Protein Degrader Development Candidate
MT Newswires
03/20 10:43
Nurix’s stock rallies on Gilead’s option
Yahoo
03/20 09:00
Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479
Yahoo
03/20 08:30
Gilead Sciences (GILD) Gains But Lags Market: What You Should Know
Yahoo
03/16 17:45
Gilead (GILD) Gains 34% in 12 Months: Will the Trend Sustain?
Yahoo
03/16 12:10
Here’s Why Gilead Sciences (GILD) Outperformed in Q4
Yahoo
03/16 07:30
Gilead Sciences (NASDAQ:GILD) Seems To Use Debt Quite Sensibly
Yahoo
03/16 07:00
Gilead Sciences (GILD) Stock Moves -0.15%: What You Should Know
Yahoo
03/15 17:50
Medicare identifies drug makers that will owe penalties for raising prices on 27 drugs faster than rate of inflation
Yahoo
03/15 15:38
First Drugs Facing Medicare Price Penalty Are Named
Yahoo
03/15 12:50
AbbVie's, Gilead's Prescription Therapies Among 27 Drugs Subject to Medicare Inflation Rebates
MT Newswires
03/15 11:11
Stacey Bledsoe's Resolve To Make Clinical Trials Available to Everyone
Yahoo
03/15 10:25
Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst institutional investors who own 84%
Yahoo
03/12 09:00
Gilead Sciences (GILD) Stock Moves -1.55%: What You Should Know
Yahoo
03/09 17:45
Gilead Sciences: Global Community Accountability Groups Pave Way Forward for Inclusive Clinical Trials
Accesswire
03/08 09:25
Is Gilead Sciences, Inc. (NASDAQ:GILD) Trading At A 50% Discount?
Yahoo
03/08 09:00
2 Healthcare Stocks That Could Help Set You Up for Life
Yahoo
03/07 09:37
RBC Trims Price Target on Gilead Sciences to $86 From $87, Maintains Sector Perform Rating
MT Newswires
03/06 08:01
What Contributed to Gilead Sciences (GILD)’s Outperformance in Q4?
Yahoo
03/06 07:29
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Yahoo
03/03 17:45
Insider Sell: Gilead Sciences
MT Newswires
03/03 01:29
Gilead Foundation Donating $1 Million for Relief Efforts in Türkiye and Syria
Yahoo
03/02 10:25
How Did Gilead Sciences, Inc.'s (NASDAQ:GILD) 22% ROE Fare Against The Industry?
Yahoo
03/02 06:00
Honoring the History and Impact of the Aids Memorial Quilt
Accesswire
02/28 09:30
Top 10 Drug Companies in USA and Their China Reliance
Yahoo
02/27 16:11
7 Cash-Rich Companies to Invest in During Economic Uncertainty
Yahoo
02/26 14:12
The one-year decline in earnings for Gilead Sciences NASDAQ:GILD) isn't encouraging, but shareholders are still up 38% over that period
Yahoo
02/26 09:00
3 Stocks to Buy Right Now That Are Cash Cows
Yahoo
02/25 06:25
WHO panel is reviewing whether COVID vaccines need updating, as agency monitors 7 omicron subvariants
Yahoo
02/24 11:40
Cambridge biotech Jounce to cut staff, merge with U.K. drug developer
Yahoo
02/23 16:26
Gilead Sciences: Black HIV/AIDS Awareness Day
Accesswire
02/23 10:30
Gilead Sciences Touts Encouraging Data From Real World Studies Of Its Flagship COVID-19 Treatment
Yahoo
02/22 11:37
Gilead Presents Positive Proof-of-Concept Data for Investigational Combination Regimen of Lenacapavir with Broadly Neutralizing Antibodies as a Potential Twice-Yearly Approach for the Treatment of HIV
Yahoo
02/22 11:21
GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill
Yahoo
02/22 11:00
Kite Completes Acquisition of Tmunity
Yahoo
02/22 09:00
Gilead Sciences Says Its COVID-19 Drug Can Help Lower Death, Hospital Readmission Rates
MT Newswires
02/22 05:21
Gilead says its COVID-19 drug can help reduce deaths, shorten hospital stays
Yahoo
02/21 17:46
Veklury® (Remdesivir) Reduced Risk of Mortality in Hospitalized COVID-19 Patients Across all Variant Time Periods in a Real World Study of More than 500,000 Hospitalized Patients
Yahoo
02/21 17:30
Gilead Presents New Data From HIV Cure Research Program and Collaborations Exploring Novel Investigational Combinations and Strategies
Yahoo
02/21 15:01
Gilead Listed on the 2023 Bloomberg Gender-Equality Index
Accesswire
02/21 09:25
Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.75
Yahoo
02/21 05:22
Gilead (GILD) Reports Positive Data From Urothelial Cancer Study
Yahoo
02/20 11:53
25 Most Profitable NASDAQ Stocks Today
Yahoo
02/20 10:34
Billionaire Ken Griffin’s Top 10 High Dividend Stock Picks
Yahoo
02/20 10:17
Gilead Sciences Says Urothelial Cancer Drug Produced Durable Response in Phase 2 Trial
MT Newswires
02/17 10:21
Mobile Clinics Expand Access to Cancer Screenings in the U.S. South
Accesswire
02/17 09:30
Trodelvy® Demonstrates Positive Efficacy Treating Both Platinum-Ineligible and Rapidly Progressing, Post-Platinum Metastatic Urothelial Cancer
Yahoo
02/17 09:00
4 Questions With Flavius Martin: Enhancing Innovation by Expanding Gilead’s Research Footprint
Accesswire
02/15 11:30
Mizuho Securities Adjusts Gilead Sciences Price Target to $101 From $88, Maintains Buy Rating
MT Newswires
02/14 10:10
Gilead Demonstrates Transformative Potential Impact Of Antiviral Innovation at CROI 2023
Yahoo
02/14 08:45
Wainwright initiates Arcellx with a buy on CAR-T pipeline, partnership with Gilead's Kite
SA Breaking News
02/13 10:57
COVID-19 emergency is ending; What it means for free vaccines and drugs
SA Breaking News
02/12 12:00
Gilead (GILD) Kite Reports Positive Data on CAR T-Cell Therapy
Yahoo
02/10 11:03
Medicare mulls rebates in 2025 for drug prices rising faster than inflation
SA Breaking News
02/10 07:18
Gilead Sciences Unit Reports Encouraging Follow-Up Data From Tecartus Study in Leukemia Patients
MT Newswires
02/09 12:19
Kite's Tecartus CAR T-Cell Therapy Demonstrates Durable Overall Survival Benefit In Leukemia Settings
Yahoo
02/09 12:17
Biotech Stock Roundup: AMGN, GILD, BMY, REGN's Q4 Results, KPRX Up on Study Update
Yahoo
02/09 12:00
2 Biotech Stocks That Could Make You Richer
Yahoo
02/09 08:00
Kite’s Tecartus® CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Yahoo
02/09 07:15
Novartis CEO to lead top U.S. pharma lobby
SA Breaking News
02/08 15:12
Gilead Sciences: 4 Questions With See Phan: Discovering New Therapies in Breast Cancer
Accesswire
02/08 08:30
--UBS Adjusts Gilead Sciences Price Target to $90 From $85, Maintains Neutral Rating
MT Newswires
02/07 10:19
Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.75
Yahoo
02/07 05:19
Gilead's (GILD) Breast Cancer Drug Trodelvy Gets FDA Nod
Yahoo
02/06 13:27
Is Gilead Sciences a Good Stock to Buy Now?
Yahoo
02/06 05:41
Research Alert: CFRA Keeps Hold Opinion On Shares Of Gilead Sciences Inc.
MT Newswires
02/06 01:05
Drug price inflation continues upward momentum at 3.8% – report
SA Breaking News
02/05 12:00
Gilead (GILD) Q4 Earnings & Sales Top on Biktarvy & Oncology
Yahoo
02/03 16:16
Gilead Snags Another Cancer Win On The Heels Of Its Best Growth In 7 Years
Yahoo
02/03 16:01
Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2022 Earnings Call Transcript
Yahoo
02/03 15:57
Strong Employment Report Undermines Risk Appetite for US Equities as Doubts Emerge Over Fed Rate Hike Pause in March
MT Newswires
02/03 13:35
Gilead Sciences' Trovelvy Scores FDA Approval For Advanced/Metastatic Breast Cancer Setting
Yahoo
02/03 12:54
Dan O'Day delivers clear Gilead message: stability, sustainability
Yahoo
02/03 12:51
15 Best Dividend Leaders to Buy According to Hedge Funds
Yahoo
02/03 12:46
--SVB Securities Adjusts Gilead Sciences Price Target to $91 From $81, Maintains Market Perform Rating
MT Newswires
02/03 11:45
Gilead wins FDA nod for Trodelvy in new breast cancer indication
SA Breaking News
02/03 10:56
Gilead Sciences Receives US FDA Approval for Breast Cancer Treatment Trodelvy
MT Newswires
02/03 10:52
UPDATE 3-Gilead's breast cancer drug gets U.S. FDA approval for third indication
Yahoo
02/03 10:50
U.S. FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer
Yahoo
02/03 10:29
--Morgan Stanley Adjusts Price Target on Gilead Sciences to $81 From $80, Maintains Equal-Weight Rating
MT Newswires
02/03 09:39
Is Gilead Sciences Stock a Screaming Buy After Its Strongest Results in 7 Years?
Yahoo
02/03 05:51
Gilead (GILD) Reports Q4 Earnings: What Key Metrics Have to Say
Yahoo
02/03 04:26
Gilead Sciences (GILD) Q4 2022 Earnings Call Transcript
Yahoo
02/02 21:00
Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates
Yahoo
02/02 17:35
Gilead stock jumps 5% after Q4 beat, dividend increase
Yahoo
02/02 17:14
Gilead Sciences Q4 Non-GAAP EPS, Revenue Increase; 2023 Outlook Issued; Shares Rise
MT Newswires
02/02 16:50
Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend
Yahoo
02/02 16:05
-- GUIDANCE: (GILD) GILEAD SCIENCES Forecasts Fiscal Year 2023 EPS Range $6.60 - $7.00
MT Newswires
02/02 16:04
-- Earnings Flash (GILD) GILEAD SCIENCES Reports Q4 Revenue $7.39B, vs. Street Est of $6.63B
MT Newswires
02/02 16:03
-- Earnings Flash (GILD) GILEAD SCIENCES Posts Q4 EPS $1.67, vs. Street Est of $1.51
MT Newswires
02/02 16:03
Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results
Yahoo
02/02 16:01
U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates
SA Breaking News
02/02 14:11
Gilead Sciences: Toward Health Equity for Black People Impacted by TNBC
Accesswire
02/02 09:00
Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others
Yahoo
02/01 10:44
Top 25 Smartest Companies To Buy According To Hedge Funds
Yahoo
02/01 10:16
Gilead awards $7.6M in grants to 24 organizations for breast cancer
SA Breaking News
02/01 09:24
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Yahoo
02/01 09:00
Gilead Awards $7.6 Million in Grants to Advance Health Equity in Breast Cancer
Yahoo
02/01 08:35
Why Gilead (GILD) Might Surprise This Earnings Season
Yahoo
02/01 08:32
Matinas BioPharma Says Gilead Sciences Abandons Joint COVID-19 Drug Project
MT Newswires
01/31 14:02
Why Gilead (GILD) is Poised to Beat Earnings Estimates Again
Yahoo
01/30 12:10
Arcellx, Kite Close Deal to Jointly Develop, Commercialize Cell Therapy Treatment for Multiple Myeloma
MT Newswires
01/30 12:05
UBS Adjusts Gilead Sciences Price Target to $85 From $71, Maintains Neutral Rating
MT Newswires
01/30 09:59
Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma
Yahoo
01/30 09:00
WHO maintains public health emergency on COVID but sees 'inflexion point' ahead
SA Breaking News
01/30 07:00
GILD, BCRX and DRS are among after hour movers
SA Breaking News
01/27 17:29
Gilead Sciences to Present at Upcoming Investor Conferences
Yahoo
01/27 16:05
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
Yahoo
01/26 17:45
Gilead Sciences (GILD) Earnings Expected to Grow: Should You Buy?
Yahoo
01/26 10:01
Could Gilead Sciences Stock Help You Become a Millionaire?
Yahoo
01/26 08:55
Companies Fight Back Against Premium Increases for Crucial Insurance
Yahoo
01/26 05:30
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
Yahoo
01/24 17:50
CDC chief to add new offices, leadership in organizational revamp
SA Breaking News
01/24 14:36
Gilead (GILD) to Report Q4 Earnings: What's in the Cards?
Yahoo
01/24 13:53
Morgan Stanley Adjusts Price Target on Gilead Sciences to $80 From $81, Maintains Equalweight Rating
MT Newswires
01/24 11:37
Gilead Sciences, Inc. (NASDAQ:GILD) Delivered A Weaker ROE Than Its Industry
Yahoo
01/24 07:00
GILD or GMAB: Which Is the Better Value Stock Right Now?
Yahoo
01/23 11:40
Gilead (GILD) Gains 21% in a Year: Will the Trend Continue?
Yahoo
01/23 10:20
Global drug spending to reach $1.9T by 2027 – IQVIA
SA Breaking News
01/22 12:00
AstraZeneca, Biogen, Bristol, and Eli Lilly among companies w/ blockbuster potential drugs
SA Breaking News
01/21 16:40
3 Smart Stocks to Buy if a Recession Is on the Way
Yahoo
01/21 06:55
The total return for Gilead Sciences (NASDAQ:GILD) investors has risen faster than earnings growth over the last three years
Yahoo
01/20 06:00
Gilead Sciences to Release Fourth Quarter & Full Year 2022 Financial Results on Thursday, February 2, 2023
Yahoo
01/19 16:05
Piper Sandler Adjusts Price Target on Gilead Sciences to $111 From $104, Maintains Overweight Rating
MT Newswires
01/19 11:26
Decades-Long Effort to Enact Universal HIV Screening for Pregnant Women in Israel
Yahoo
01/19 09:00
Gilead plans 175,000-square-foot research center in Foster City
Yahoo
01/18 10:44
Covid Isn’t Going Away. New Drugs Are Coming.
Yahoo
01/18 09:00
Barclays Adjusts Price Target on Gilead Sciences to $84 From $76, Maintains Equal-Weight Rating
MT Newswires
01/18 08:51
3 Stocks That Beat the S&P During the Great Recession
Yahoo
01/18 06:35
Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know
Yahoo
01/17 17:50
With 82% ownership of the shares, Gilead Sciences, Inc. (NASDAQ:GILD) is heavily dominated by institutional owners
Yahoo
01/16 07:00
Drugmakers welcome new year with 450 drug price hikes so far
SA Breaking News
01/15 12:00
25 Biggest California Companies and Stocks
Yahoo
01/15 10:00
Omicron subvariant XBB.1.5 makes up 43% of COVID cases in U.S. – CDC
SA Breaking News
01/13 10:54
Meet Gilead’s COVID-19 Virus Variants Hunters
Accesswire
01/12 09:00
Gilead Sciences (GILD) Gains But Lags Market: What You Should Know
Yahoo
01/11 17:50
Top Dividend Stock: Gilead Sciences Nears Buy Point Ahead of Earnings
Yahoo
01/11 10:08
2 Unstoppable Stocks That Could Beat the Market Again In 2023
Yahoo
01/11 08:45
Update: US Supreme Court Rejects Bristol-Myers Squibb's Renewed Bid Over $1.2 Billion Patent Fight With Gilead Sciences
MT Newswires
01/09 17:36
US Supreme Court Rejects Bristol-Myers Squibb's Renewed Bid Over $1.2 Billion Patent Fight With Gilead Sciences
MT Newswires
01/09 15:33
Economic Forecast 2023: New challenges in biotech's 'valley of death'
Yahoo
01/06 08:00
Does Gilead Sciences (NASDAQ:GILD) Have A Healthy Balance Sheet?
Yahoo
01/06 06:01
Gilead Sciences Again Named to Dow Jones Sustainability World Index
Yahoo
01/05 13:50
Gilead Sciences (GILD) Gains But Lags Market: What You Should Know
Yahoo
01/04 17:50
HOOKIPA Pharma achieves $5M milestone payment under collaboration with Gilead
SA Breaking News
01/04 13:07
Gilead's (GILD) Application for Trodelvy Gets EMA Validation
Yahoo
01/04 11:45
Gilead Sciences: Connecting Breast Cancer Education to Community: Equal Hope
Accesswire
01/04 10:00
Allogene ends winning streak as R&D chief departs
SA Breaking News
01/03 12:01
EMA approves change to marketing authorization for Gilead's breast cancer drug Trodelvy
SA Breaking News
01/03 10:38
Gilead Sciences Says EU Regulator Validates Marketing Authorization Application for Breast Cancer Drug Candidate Trodelvy
MT Newswires
01/03 10:35
Wells Fargo Boosts Price Target on Gilead Sciences to $90 From $75, Keeps Equalweight Rating
MT Newswires
01/03 10:20
Gilead Sciences Signs Collaboration, Licensing Deal With EVOQ Therapeutics to Treat Rheumatoid Arthritis, Lupus
MT Newswires
01/03 09:24
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
Yahoo
01/03 08:30
European Medicines Agency Validates Marketing Authorization Application For Trodelvy® (sacituzumab govitecan-hziy) For Pre-treated HR+/HER2- Metastatic Breast Cancer
Yahoo
01/03 08:30
Gilead downgraded at RBC Capital Markets after recent rally
SA Breaking News
01/03 08:19
Gilead Sciences Downgraded by RBC to Sector Perform From Outperform After Stock Outperformance, Keeps Price Target at $87
MT Newswires
01/03 08:10
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
Yahoo
01/02 09:00
Why Investors Shouldn't Be Surprised By Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E
Yahoo
01/02 06:00
Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks
Yahoo
12/31 17:52
Gilead Sciences (GILD) Gains But Lags Market: What You Should Know
Yahoo
12/29 17:45
Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More
Yahoo
12/29 11:36
This New Drug Could Be Gilead Sciences' Growth Catalyst
Yahoo
12/29 09:20
3 High-Yielding Dividend Stocks That Could See Hikes in January
Yahoo
12/29 09:00
Are Investors Undervaluing Gilead Sciences, Inc. (NASDAQ:GILD) By 40%?
Yahoo
12/29 06:00
Sector Update: Healthcare Stocks Losing Ground Late in Wednesday Trading
MT Newswires
12/28 16:02
Biotech: 3 Profitable Bios Worth Owning
Yahoo
12/28 14:19
Sector Update: Health Care Stocks Still Trying to Establish Direction
MT Newswires
12/28 14:12
Gilead (GILD) To Get Full Rights for Jounce's Immunotherapy
Yahoo
12/28 10:59
Gilead Sciences Acquires Jounce Therapeutics Cancer Immunotherapy Program
Yahoo
12/28 09:14
Sector Update: Health Care Stocks Increase Premarket Wednesday
MT Newswires
12/28 09:04
Pending Home Sales Outlook Prompts Muted Premarket Action for US Equity Futures
MT Newswires
12/28 08:57
Top Premarket Gainers
MT Newswires
12/28 07:51
Zacks Industry Outlook Highlights Gilead Sciences, GSK, Immunocore and Syndax Pharmaceuticals
Yahoo
12/28 07:15
Gilead buys out rights to cancer therapy from Jounce for $67 million
Yahoo
12/27 21:34
Gilead Sciences to Acquire Rights to Immunotherapy GS-1811 From Jounce Therapeutics
MT Newswires
12/27 16:58
Gilead To Acquire All Remaining Rights To Potential First-In-Class Immunotherapy GS-1811 From Jounce Therapeutics
Globe Newswire
12/27 16:30
Gilead Sciences Receives FDA Approval for Sunlenca to Treat HIV
MT Newswires
12/22 13:27
Gilead Sciences Says FDA Approves Sunlenca for Treatment of Multi-Drug Resistant HIV Infection
MT Newswires
12/22 11:22
Gilead Sciences: Tatiana Williams Leads the Way With the Transinclusive Group
Accesswire
12/21 09:30
Gilead's Kite unit to acquire CAR T therapy developer Tmunity Therapeutics
SA Breaking News
12/20 09:05
Gilead Sciences' Kite Pharma Agrees to Acquire Tmunity Therapeutics
MT Newswires
12/20 08:37
It's almost 2023, but here are the drugs the FDA could approve before the end of the year
SA Breaking News
12/17 16:00
Catalyst watch: Tesla looks to end skid, Nike earnings, Rocket Lab launch and Broadcom-VMware review
SA Breaking News
12/16 15:00
Gilead Sciences' Kite Says Follow-Up Analysis of Yescarta CAR T-Cell Therapy Shows Continued Response from 52% of Patients
MT Newswires
12/12 16:27
Gilead Sciences' Kite, Arcellx to Develop, Commercialize Cell Therapy Treatment for Multiple Myeloma
MT Newswires
12/09 09:02
Higher-Than-Expected Rise in Producer Prices Weighs on US Equity Futures
MT Newswires
12/09 08:53
Producer Prices Data Eyed as Exchange-Traded Funds, Stock Futures Rise Pre-Bell Friday
MT Newswires
12/09 08:24
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
PR Newswire
12/09 08:15
ImmunoGen, Gilead Sciences Working Together to Assess Drug Combination in Patients With Acute Myeloid Leukemia
MT Newswires
12/09 07:26
ImmunoGen stock rises on team up with Gilead for blood cancer study
SA Breaking News
12/09 06:52
Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus' Story
Accesswire
12/08 09:40
Gilead Sciences' Kite Pharma Unit, Daiichi Sankyo Amend Licensing Deal for Cancer Therapy in Japan
MT Newswires
12/08 06:16
Philip Morris, Starbucks among new ideas in BofA's Alpha Surprise screen
SA Breaking News
12/07 05:04
Gilead slips as trial for cancer drug ends on safety concerns
SA Breaking News
12/05 13:29
Oppenheimer Adjusts Gilead Sciences Price Target to $105 From $95, Maintains Outperform Rating
MT Newswires
12/01 08:36
Gilead Sciences Says EC Okays Low-Dose Tablet, Indication Extension for Biktarvy to Treat HIV in Pediatric Populations
MT Newswires
11/29 10:28
Gilead gets European approval for use of HIV drug Biktarvy in children
SA Breaking News
11/29 10:10
Gilead, Arcus Report Positive Update on Interim Analysis of Mid-Stage Lung Cancer Study
MT Newswires
11/28 14:47
Gilead and Arcus issue update from mid-stage trial for lung cancer therapy
SA Breaking News
11/28 08:59
ImmunoGen drops 11% amid plans to launch $6K cancer drug
SA Breaking News
11/15 14:58
U.S. COVID health emergency to stay in place
SA Breaking News
11/12 20:59
Insider Sell: Gilead Sciences
MT Newswires
11/10 16:44
--Cowen Adjusts Price Target on Gilead Sciences to $90 From $80, Maintains Outperform Rating
MT Newswires
11/08 11:48
--Mizuho Raises Price Target for Gilead Sciences to $88 From $75, Maintains Buy Rating
MT Newswires
11/07 09:48
Eli Lilly COVID-19 therapy unlikely to neutralize new Omicron subvariants - FDA
SA Breaking News
11/04 11:31
Insider Sell: Gilead Sciences
MT Newswires
11/02 17:04
Jounce Therapeutics Earns $15 Million Milestone Payment from Gilead Sciences
MT Newswires
11/02 12:01
Gilead Sciences Gets FDA Nod for Vemlidy to Treat Hepatitis B Virus Infection in Children
MT Newswires
11/02 10:44
AnaptysBio raised to Buy at Guggenheim on prospects for checkpoint agonists
SA Breaking News
11/01 12:30
--SVB Securities Raises Price Target on Gilead Sciences to $81 From $68, Keeps Market Perform Rating
MT Newswires
11/01 10:21
--UBS Raises Gilead Sciences' Price Target to $71 From $66 After 'Solid' Q3, Keeps Neutral Rating
MT Newswires
10/31 12:17
Research Alert: CFRA Keeps Hold Opinion On Shares Of Gilead Sciences
MT Newswires
10/31 11:00
--Maxim Adjusts Price Target on Gilead Sciences to $92 From $84, Maintains Buy Rating
MT Newswires
10/31 09:41
--Barclays Upgrades Gilead Sciences to Equalweight From Underweight, Adjusts Price Target to $76 From $60
MT Newswires
10/31 09:28
Hot Stocks: AMZN, EW drop on earnings; DXCM, GILD surge
SA Breaking News
10/28 18:07
Sector Update: Health Care Stocks Picking Up Late Strength on Friday
MT Newswires
10/28 16:07
Sector Update: Health Care Stocks Posting Modest Friday Advance Despite Big Boost from Biotech Companies
MT Newswires
10/28 13:44
Top Midday Gainers
MT Newswires
10/28 13:34
Gilead Sciences Shares Rise After Analyst Upgrades Follow Company's Forecast-Beating Q3 Results, Increased Guidance
MT Newswires
10/28 13:09
--Morgan Stanley Adjusts Price Target on Gilead Sciences to $68 From $67, Reiterates Equalweight Rating
MT Newswires
10/28 13:04
--Wells Fargo Adjusts Price Target on Gilead Sciences to $75 From $74, Keeps Equalweight Rating
MT Newswires
10/28 10:46
Thinking about trading options or stock in Apple, Intel Corp, Gilead Sciences, T-Mobile, or Chevron?
PR Newswire
10/28 09:31
--RBC Raises Price Target on Gilead Sciences to $82 From $79 After 'Strong' Q3, Maintains Outperform Rating
MT Newswires
10/28 08:22
--Piper Sandler Upgrades Gilead Sciences to Overweight From Neutral, Adjusts Price Target to $96 From $79
MT Newswires
10/28 06:14
--Truist Securities Upgrades Gilead Sciences to Buy From Hold, Adjusts Price Target to $91 From $76
MT Newswires
10/28 05:41
Gilead Sciences Q3 Tops Estimates; Raises Full-Year 2022 Guidance -- Shares Up 3% After-Hours
MT Newswires
10/27 16:30
-- Earnings Flash (GILD) GILEAD SCIENCES Posts Q3 EPS $1.90, vs. Street Est of $1.43
MT Newswires
10/27 16:03
-- Earnings Flash (GILD) GILEAD SCIENCES Posts Q3 Revenue $7.04B, vs. Street Est of $6.13B
MT Newswires
10/27 16:03
Earnings Reaction History: Gilead Sciences, 63.6% Follow-Through Indicator, 3.1% Sensitive
MT Newswires
10/27 12:18
Will Gilead Q3 results bring positive surprise with focus on cancer portfolio?
SA Breaking News
10/27 10:35
Gilead Sciences Says Real-World Data Backs Safety, Efficacy of HIV Regimen
MT Newswires
10/24 05:43
--UBS Adjusts Gilead Sciences' Price Target to $66 From $65, Maintains Neutral Rating
MT Newswires
10/21 10:00
Gilead Sciences Unit Enters Into License Deal With Refuge Biotechnologies to Develop Blood Cancer Therapies
MT Newswires
10/20 10:33
Gilead's Kite gains license to Refuge Biotechnologies platform for blood cancer treatments
SA Breaking News
10/20 10:01
Gilead COVID-19 antiviral remdesivir sent to fight Ebola in Africa
SA Breaking News
10/19 10:39
Gilead Sciences Subsidiary Gets European Commission Approval for B-cell Lymphoma Treatment
MT Newswires
10/17 17:05
Morgan Stanely says large cap healthcare remains attractive amid macro concerns
SA Breaking News
10/17 10:34
Gilead Sciences, MacroGenics to Develop Potential Blood Cancer Treatment MGD024
MT Newswires
10/17 10:07